Taiwan FDA registration 773e10b461c0c85b767852023afb0e7e

Abbott clinical biochemical immunoglobulin G test group

TW: 亞培臨床生化免疫球蛋白G檢驗試劑組
Taiwan flagTaiwan·Risk Class 2·ABBOTT IRELAND DIAGNOSTICS DIVISION·Registered Jan 25, 2022 – Jan 25, 2027Active
Registration details
Analysis ID
773e10b461c0c85b767852023afb0e7e
Customs Code
DHA05603521109
Company information
Manufacturer Country
Ireland
Product details
Intended Use
This product is used to quantify IgG in human serum or plasma on the ARCHITECT c system.
Product Type (Level 1)
C Immunology and microbiology
Product Type (Level 2)
C.5510 免疫球蛋白A,G,M,D及E免疫試驗系統
Import Information
QMS/QSD;; 輸入
Dates and status
Registration Date
Jan 25, 2022
Expiry Date
Jan 25, 2027
Companies making similar products

Top companies providing products similar to "Abbott clinical biochemical immunoglobulin G test group"

Recent registrations

Recently registered similar products

About this record

Access comprehensive regulatory information for Abbott clinical biochemical immunoglobulin G test group in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 773e10b461c0c85b767852023afb0e7e and manufactured by ABBOTT IRELAND DIAGNOSTICS DIVISION. The authorized representative in Taiwan is ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.).

This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including FISHER DIAGNOSTICS, A DIVISION OF FISHER SCIENTIFIC COMPANY, LLC, A PART OF THERMO FISHER SCIENTIFIC INC.;; ABBOTT GMBH, and 1 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices1 Competitors1 Recent Registrations